Exchange: NASDAQ·Updated 12:31 PM EDT
About ABP
Abpro Holdings, Inc. is a biotechnology company focused on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease. The company was founded in 2004 and is headquartered in Burlington, MA.